Literature DB >> 16466404

Attitude towards antipsychotics among out-patients with schizophrenia in Nigeria.

A O Adewuya1, B A Ola, S K Mosaku, F O Fatoye, A B Eegunranti.   

Abstract

OBJECTIVE: The study aim to assess the attitude of patients with schizophrenia attending out-patient clinics in Nigeria towards antipsychotic medication and examine the factors associated with such attitude.
METHOD: Out-patients with schizophrenia (n = 312) completed the 10-item Drug Attitude Inventory. They were also evaluated for sociodemographic details, illness-related and drug-related variables.
RESULTS: Overall, the patients had a good attitude towards antipsychotic medication. The factors significantly associated with poor attitude towards medication include presence of symptoms, presence of side-effects like dyskinesia and sedation, lack of insight into the illness, and being employed.
CONCLUSION: Special attention should be paid to patients with these factors while designing programmes to improve overall compliance in patients with schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16466404     DOI: 10.1111/j.1600-0447.2005.00745.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  14 in total

1.  Social interaction and drug attitude effectiveness in patients with schizophrenia.

Authors:  Jui-Kang Tsai; Wen-Kuo Lin; For-Wey Lung
Journal:  Psychiatr Q       Date:  2011-12

2.  Attitudes toward taking medication among outpatients with schizophrenia: cross-national comparison between Tokyo and Beijing.

Authors:  Naoaki Kuroda; Shiyou Sun; Chih-Kuang Lin; Nobuaki Morita; Hirotaka Kashiwase; Fude Yang; Yoji Nakatani
Journal:  Environ Health Prev Med       Date:  2008-08-12       Impact factor: 3.674

3.  Description of study population and analysis of factors influencing adherence in the observational Italian study "Evaluation of Pharmacotherapy Adherence in Bipolar Disorder" (EPHAR).

Authors:  Alessandra Barraco; Andrea Rossi; Giuseppe Nicolò
Journal:  CNS Neurosci Ther       Date:  2010-12-28       Impact factor: 5.243

Review 4.  Defining and assessing adherence to oral antipsychotics: a review of the literature.

Authors:  Dawn I Velligan; Yui-Wing Francis Lam; David C Glahn; Jennifer A Barrett; Natalie J Maples; Larry Ereshefsky; Alexander L Miller
Journal:  Schizophr Bull       Date:  2006-05-17       Impact factor: 9.306

5.  Attitude and preferences towards oral and long-acting injectable antipsychotics in patients with psychosis in KwaZulu-Natal, South Africa.

Authors:  Krishanand R Roopun; Andrew Tomita; Saeeda Paruk
Journal:  S Afr J Psychiatr       Date:  2020-07-27       Impact factor: 1.550

6.  Patients' preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study.

Authors:  Istvan Bitter; Tamás Treuer; Nesrin Dilbaz; Igor Oyffe; Eda M Ciorabai; Severiano L Gonzalez; Sandra Ruschel; Jolanta Salburg; Yulia Dyachkova
Journal:  World J Biol Psychiatry       Date:  2010-10       Impact factor: 4.132

7.  Barriers to mental health services utilization in the Niger Delta region of Nigeria: service users' perspectives.

Authors:  Izibeloko Omi Jack-Ide; Leana Uys
Journal:  Pan Afr Med J       Date:  2013-04-24

8.  Attitudes toward Medication and Reasons for Non-Compliance in Patients with Schizophrenia.

Authors:  Ivatury Sarath Chandra; Kalasapati Lokesh Kumar; Mallepalli Pramod Reddy; Chada Muni Pavan Kumar Reddy
Journal:  Indian J Psychol Med       Date:  2014-07

9.  Attitudes toward psychotropic medications among patients with chronic psychiatric disorders and their family caregivers.

Authors:  Sandeep Grover; Subho Chakrabarti; Aarti Sharma; Shikha Tyagi
Journal:  J Neurosci Rural Pract       Date:  2014-10

10.  Attitudes towards antipsychotics among patients with schizophrenia on first- or second-generation medications.

Authors:  M S Karthik; Nisha Warikoo; Subho Chakrabarti; Sandeep Grover; Parmanand Kulhara
Journal:  Indian J Psychol Med       Date:  2014-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.